AnaptysBio, Inc. (FRA:AN6)
Germany
· Delayed Price · Currency is EUR 37.80
+1.20 (3.28%)
At close: Dec 5, 2025
AnaptysBio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 169.47 | 91.28 | 17.16 | 10.29 | 63.18 | 75 | Upgrade
|
| Revenue Growth (YoY) | 196.42% | 432.03% | 66.78% | -83.72% | -15.77% | 837.50% | Upgrade
|
| Cost of Revenue | 153 | 163.84 | 132.28 | 88.8 | 98.5 | 80.03 | Upgrade
|
| Gross Profit | 16.47 | -72.56 | -115.13 | -78.51 | -35.32 | -5.03 | Upgrade
|
| Selling, General & Admin | 45.14 | 42.39 | 41.95 | 36.64 | 21.49 | 18.85 | Upgrade
|
| Operating Expenses | 45.14 | 42.39 | 41.95 | 36.64 | 21.49 | 18.85 | Upgrade
|
| Operating Income | -28.68 | -114.95 | -157.07 | -115.15 | -56.81 | -23.88 | Upgrade
|
| Interest Expense | -77.59 | -50.09 | -18.08 | -21.11 | -1.45 | - | Upgrade
|
| Interest & Investment Income | 16.25 | 19.79 | 18.87 | 7.55 | 0.43 | 3.96 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.01 | 0.01 | -0 | 0.01 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 5.44 | - | - | - | 0.04 | -0.01 | Upgrade
|
| EBT Excluding Unusual Items | -84.55 | -145.23 | -156.28 | -128.7 | -57.8 | -19.93 | Upgrade
|
| Pretax Income | -84.55 | -145.23 | -163.62 | -128.7 | -57.8 | -19.93 | Upgrade
|
| Income Tax Expense | 0.08 | 0 | -0 | 0.02 | - | - | Upgrade
|
| Net Income | -84.63 | -145.23 | -163.62 | -128.72 | -57.8 | -19.93 | Upgrade
|
| Net Income to Common | -84.63 | -145.23 | -163.62 | -128.72 | -57.8 | -19.93 | Upgrade
|
| Shares Outstanding (Basic) | 29 | 28 | 27 | 28 | 27 | 27 | Upgrade
|
| Shares Outstanding (Diluted) | 29 | 28 | 27 | 28 | 27 | 27 | Upgrade
|
| Shares Change (YoY) | 7.36% | 5.42% | -4.41% | 2.68% | 0.47% | 0.90% | Upgrade
|
| EPS (Basic) | -2.88 | -5.12 | -6.08 | -4.57 | -2.11 | -0.73 | Upgrade
|
| EPS (Diluted) | -2.88 | -5.12 | -6.08 | -4.57 | -2.11 | -0.73 | Upgrade
|
| Free Cash Flow | -145.32 | -135.7 | -121.61 | -73.95 | -47.29 | -14.73 | Upgrade
|
| Free Cash Flow Per Share | -4.94 | -4.78 | -4.52 | -2.63 | -1.72 | -0.54 | Upgrade
|
| Gross Margin | 9.72% | -79.49% | - | - | -55.91% | -6.70% | Upgrade
|
| Operating Margin | -16.92% | -125.93% | -915.50% | -1119.41% | -89.93% | -31.84% | Upgrade
|
| Profit Margin | -49.94% | -159.11% | -953.66% | -1251.33% | -91.49% | -26.57% | Upgrade
|
| Free Cash Flow Margin | -85.75% | -148.66% | -708.79% | -718.88% | -74.85% | -19.63% | Upgrade
|
| EBITDA | -28.1 | -114.34 | -156.42 | -114.48 | -56.2 | -23.32 | Upgrade
|
| EBITDA Margin | -16.58% | -125.27% | - | - | -88.95% | -31.09% | Upgrade
|
| D&A For EBITDA | 0.57 | 0.61 | 0.65 | 0.68 | 0.62 | 0.56 | Upgrade
|
| EBIT | -28.68 | -114.95 | -157.07 | -115.15 | -56.81 | -23.88 | Upgrade
|
| EBIT Margin | -16.92% | -125.93% | - | - | -89.93% | -31.84% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.